Pharmacoepidemiology and Drug Safety

© John Wiley & Sons, Ltd.

Cover image for Pharmacoepidemiology and Drug Safety

November 2008

Volume 17, Issue 11

Pages 1039–1130, i–xvi

  1. Original Reports

    1. Top of page
    2. Original Reports
    3. Current Awareness
    1. Long-term use of antihypertensive drugs and risk of cancer (pages 1039–1049)

      Themistocles L. Assimes, Eleanor Elstein, Adrian Langleben and Samy Suissa

      Article first published online: 9 SEP 2008 | DOI: 10.1002/pds.1656

    2. Detecting signals of opioid analgesic abuse: application of a spatial mixed effect poisson regression model using data from a network of poison control centers (pages 1050–1059)

      Meredith Y. Smith, William Irish, Jianmin Wang, J. David Haddox and Richard C. Dart

      Article first published online: 22 SEP 2008 | DOI: 10.1002/pds.1658

    3. Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in women (pages 1060–1067)

      Yujia Zhang, Stacey W. Martin, Charles E. Rose Jr, Raymond E. Biagini, Laura H. Franzke, Jerry P. Smith, Deborah L. Sammons, Shirley A. Robertson and Michael M. McNeil

      Article first published online: 10 SEP 2008 | DOI: 10.1002/pds.1657

    4. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system (pages 1068–1076)

      Eric Colman, Ana Szarfman, Jo Wyeth, Andrew Mosholder, Devanand Jillapalli, Jonathan Levine and Mark Avigan

      Article first published online: 29 SEP 2008 | DOI: 10.1002/pds.1643

    5. Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use (pages 1077–1090)

      R. Ostini, D. Hegney, J. M. Mackson, M. Williamson and S. E. Tett

      Article first published online: 13 AUG 2008 | DOI: 10.1002/pds.1638

    6. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia (pages 1091–1099)

      Anna Hynd, Elizabeth E. Roughead, David B. Preen, John Glover, Max Bulsara and James Semmens

      Article first published online: 29 SEP 2008 | DOI: 10.1002/pds.1670

    7. Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model (pages 1100–1107)

      A. Villaverde-Hueso, M. Posada de la Paz, M. C. Martín-Arribas, E. Sánchez-Valle, A. Ramírez-González and P. Biairdi

      Article first published online: 24 SEP 2008 | DOI: 10.1002/pds.1660

    8. Nimesulide associated fulminant hepatic failure (pages 1108–1112)

      Sarah L. Walker, Fionnuala Kennedy, Nolan Niamh and P. Aiden McCormick

      Article first published online: 29 SEP 2008 | DOI: 10.1002/pds.1665

    9. Effects of an evidence report and policies lifting reimbursement restrictions for acid suppressants: analysis of the Belgian national database (pages 1113–1122)

      Mieke L. van Driel, Robert Vander Stichele, Monique Elseviers, An De Sutter, Jan De Maeseneer and Thierry Christiaens

      Article first published online: 30 SEP 2008 | DOI: 10.1002/pds.1664

    10. Medicine utilisation review in selected non-governmental organisations primary healthcare clinics in the West Bank in Palestine (pages 1123–1130)

      R. Khatib, A. Daoud, N.M.E. Abu-Rmeileh, A. Mataria and D. McCaig

      Article first published online: 24 SEP 2008 | DOI: 10.1002/pds.1662

  2. Current Awareness

    1. Top of page
    2. Original Reports
    3. Current Awareness
    1. Current awareness: Pharmacoepidemiology and drug safety (pages i–xvi)

      Article first published online: 23 OCT 2008 | DOI: 10.1002/pds.1492

SEARCH

SEARCH BY CITATION